Results 11 to 20 of about 27,580 (305)
International Journal of Oral ScienceAmeloblastoma is a benign tumor characterized by locally invasive phenotypes, leading to facial bone destruction and a high recurrence rate. However, the mechanisms governing tumor initiation and recurrence are poorly understood.
Gan Xiong +19 more
doaj +2 more sources
Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation
Scientific Reports, 2021 Ameloblastoma is a benign, epithelial cancer of the jawbone, which causes bone resorption and disfigurement to patients affected. The interaction of ameloblastoma with its tumour stroma drives invasion and progression.
Deniz Bakkalci +11 more
doaj +2 more sources
Clinicopathologic Profile, Management and Outcome of Sinonasal Ameloblastoma—A Systematic Review
Journal of Clinical Medicine, 2023 Sinonasal ameloblastoma (SNA) is considered to be a subtype of ameloblastoma. It differs from gnathic ameloblastoma in terms of clinicopathologic features, management and prognosis. Thus, the objective of the present review was to study the complications,
Vini Mehta +6 more
semanticscholar +1 more source
Revista da Faculdade de Odontologia de Porto Alegre, 2022 Estudo, sob o ponto de vista cIínico, radiológico e principalmente histopatológico, de casos de ameloblastoma, alguns dos quais foi feita ressecção e em outros não. Estudou-se também as tendências à recidiva.
João Jorge Diniz Barbachan +1 more
openaire +3 more sources
Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor
Cureus, 2022 Ameloblastoma is one of the most common benign odontogenic tumors of the jaw that constitutes about 10% of all tumors that arise in the mandible and maxilla.
S. Ghai
semanticscholar +1 more source
Medical Oncology, 2023 Background Ameloblastoma in 66% of the cases harbor a somatic mutation of the “mitogen-activated protein kinase” signaling pathway (BRAF V600E). In V600E mutations, BRAF is in the permanent “on” state and relays the growth-promoting signals independently
M. Ebeling +5 more
semanticscholar +1 more source
BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis
Cancers, 2022 Simple Summary Ameloblastoma is a benign odontogenic tumour, and the patient always presents at a later stage when the tumour is already in an aggressive state.
Mohd Nazzary Mamat Yusof +2 more
semanticscholar +1 more source
Asian Pacific Journal of Cancer Prevention, 2022 Introduction: Ameloblastoma is regarded as the second most prevalent odontogenic tumor in the light of its prevalence, clinical characteristics, greater incidence of tumor recurrence, and therapeutic challenges.
Yoithapprabhunath Thuckanaickenpalayam Ragunathan +5 more
semanticscholar +1 more source
Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma
Journal of Personalized Medicine, 2022 Ameloblastoma is the most common benign odontogenic neoplasm, but with an aggressive behavior and a high recurrence rate. Nowadays wide surgical resection is the current recommended treatment, which can cause further loss of function and esthetics ...
C. Tseng +3 more
semanticscholar +1 more source